Targeting B cell responses in universal influenza vaccine design. - Wikidata - wikimedia - TriplyDB

Targeting B cell responses in universal influenza vaccine design.

Targeting B cell responses in universal influenza vaccine design.

http://www.wikidata.org/entity/Q35540405

about

Vaccines: from empirical development to rational design Modeling Influenza Virus Infection: A Roadmap for Influenza Research Antibodies in HIV-1 vaccine development and therapy Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.Immune history profoundly affects broadly protective B cell responses to influenza.Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem.Novel viral vectored vaccines for the prevention of influenza.AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans.Inhibition of highly pathogenic avian influenza (HPAI) virus by a peptide derived from vFLIP through its direct destabilization of viruses.Fast vaccine design and development based on correlates of protection (COPs).High preexisting serological antibody levels correlate with diversification of the influenza vaccine response High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination.Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins.Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection.Vaccine efficacy and T helper cell differentiation change with aging.Cutting edge: Expression of FcγRIIB tempers memory CD8 T cell function in vivo.Detection of influenza A/H1N1-specific human IgG-secreting B cells in older adults by ELISPOT assay.Emerging roles for protein S-palmitoylation in immunity from chemical proteomics.To dream the impossible dream: universal influenza vaccination.Restricted, canonical, stereotyped and convergent immunoglobulin responses.Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation.A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques.Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination.Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection.Platform technology to generate broadly cross-reactive antibodies to α-helical epitopes in hemagglutinin proteins from influenza a viruses.Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza.ICAMs support B cell interactions with T follicular helper cells and promote clonal selection.

P2860

Q21089599-8D155736-8584-4621-9ED2-0881D82D2810 Q26782421-4544EC65-04DE-4D4A-A2A2-74900341C01B Q27011574-AE7A6F06-1B64-4AE1-9A1F-0DB0D5E831F2 Q30207890-FE7F1E28-B593-4FF2-81EF-08946AA6283E Q30355629-72C40A15-6895-43B1-8AE9-9832F50C9184 Q30371836-8E5C2D0A-32D3-48B0-B116-BB76CEC6E5C5 Q30382131-5DAD94EA-FCCF-4530-911B-2FA7DB36EE20 Q30413677-27C904A8-914F-470E-BCA2-CAFC51FC7B95 Q30416784-9D0459F1-6FAA-4D69-B217-DB70ABEE4FA2 Q30418570-34068C16-C5D0-49B3-AFAE-CF7AC71FC7CB Q30421821-D7E69288-1131-4232-9F55-3341B6E0661A Q33884759-1051EBD1-3643-4404-A45F-ED2E7E46F2BA Q34291098-F580F283-E449-4BF5-B4AB-1A04C8C955A2 Q35110980-81F135E5-B635-4715-A11C-40F35A8EA3CE Q35624357-17AE9880-74D4-46C6-9220-0B1D28036D7A Q36950550-9B471FE1-6BF6-41BA-A7BA-D2D910633FD5 Q36991414-42F8502D-BABD-44B2-B4F2-A840A6E6BBBD Q37093491-A0DE5093-B6DE-4398-93D8-5BBA19BFF604 Q37104756-26E59EFD-6271-4AE4-9188-3ECB4600B8E5 Q37376099-2108E2D9-6A21-499F-A376-EE6D3AA5EDDF Q37418280-7365F18D-EEA0-43C3-BE4C-8CD2FF61FAD0 Q37629980-86FB8FBD-07F7-4119-BBFC-2C827D6AC790 Q38075225-B5048907-6D07-4157-81A8-30442A36081B Q38120113-F9EDA968-7444-40FB-BF1C-7E1098ADC573 Q38551067-8EB1C475-C551-4A95-B950-A8D39AF01106 Q38636875-F8692071-0F43-41D4-828A-097CC5648251 Q38644429-579D5699-5278-49FA-98EC-964EAF9E8196 Q38804059-AEB94A5C-B6A7-4647-9D44-8760FEF313B0 Q39115372-576BFF88-3B6B-464F-8EA1-C4A7C65BDA34 Q39310460-2C7E89CD-05DD-4C3F-950F-6E5D2BC3E16E Q40957364-6B42C802-B003-400C-8366-62153A2E1598 Q41942589-5C788038-7E4A-469A-80EC-A8F6AA043E9D Q47759018-B4FF74C7-10E7-4EAB-96D7-C78E17217D73

P2860

Targeting B cell responses in universal influenza vaccine design.

http://www.wikidata.org/entity/Q35540405

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Targeting B cell responses in universal influenza vaccine design.

@ast

Targeting B cell responses in universal influenza vaccine design.

@en

type

label

Targeting B cell responses in universal influenza vaccine design.

@ast

Targeting B cell responses in universal influenza vaccine design.

@en

prefLabel

Targeting B cell responses in universal influenza vaccine design.

@ast

Targeting B cell responses in universal influenza vaccine design.

@en

P1433

Q35540405-29F8E7B8-B7B1-4C73-98E0-AF10BF7A3FA8

P1476

Q35540405-04D45414-1E8B-47A0-A4AA-E4AD818E3F5D

P2093

Q35540405-10700D85-AAE7-4E62-B6B8-66D6F9999F9E

Q35540405-33BC1110-5D19-4C3B-BB56-653D3A3C17AD

Q35540405-B0444B05-F7A9-4A25-8B80-946FDE1E68DB

P2860

Q35540405-019B793B-C8B9-429E-A05B-BCC167C29E99

Q35540405-042A4396-A773-45EB-9A4D-D05E668A6AB4

Q35540405-043A08F9-F4E7-4760-BB80-ED7A6FC3672E

Q35540405-05B2867F-60C0-4BF5-8D62-23B3399035A6

Q35540405-0BF8DAB4-D1B3-48BB-B1F9-2097E7938BFF

Q35540405-0C00117F-5496-48EF-9287-06F56C778E31

Q35540405-0FF4ABCB-8333-417A-BD82-65DBDA46E6B3

Q35540405-10CDA42B-E953-4119-9700-7CF8716E3F5B

Q35540405-1BEF0B26-7FDD-4947-9BF9-213498E044CB

Q35540405-306E29E4-0905-4270-8266-641568D23E2D

P304

Q35540405-C7071815-2336-4A9F-B447-D1CE2BA3E98C

P31

Q35540405-CF8BDAF8-29B4-432A-8241-383C15AC83B8

P356

Q35540405-C8DB1571-6294-44C6-B5FA-AF1E1C63DCE3

P433

Q35540405-D7106C70-5026-4324-B10B-6B2AABA24597

P478

Q35540405-B87D49F5-8780-456B-8D86-F12B04B201F8

P577

Q35540405-3D5891E4-1879-48FF-B043-B299F35705DF

P5875

Q35540405-5B8E6A00-FF88-4E5E-BED8-3F85A8EB6A13

P698

Q35540405-7F550CA6-BCFE-4F7D-B5C3-47E90F67CAE4

P932

Q35540405-11C9F5E8-D204-4DEA-BE26-9D0C1DE54262

P356

J.IT.2011.08.007

P1433

Trends in Immunology

P1476

Targeting B cell responses in universal influenza vaccine design.

@en

P2093

Kaval Kaur

http://www.w3.org/2001/XMLSchema#string

Meghan Sullivan

http://www.w3.org/2001/XMLSchema#string

Patrick C Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

Influenza pandemics of the 20th century

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

A highly conserved neutralizing epitope on group 2 influenza A viruses

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

Influenza A virus neuraminidase limits viral superinfection

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid

P304

524-531

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IT.2011.08.007

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51663721

http://www.w3.org/2001/XMLSchema#string

P698

21940217

http://www.w3.org/2001/XMLSchema#string

P932

3212832

http://www.w3.org/2001/XMLSchema#string